Segment Results (Schedule Of Reconciliations Of Consolidated Adjusted Income (Loss) Before Income Tax) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Segment Reporting Information [Line Items]
Total consolidated loss from continuing operations before income tax									$ (3,923,856)	$ (1,437,864)	$ 99,875
Interest expense, net									452,679	373,214	227,114
Amortization of intangible assets									876,451	561,300	218,700
Acceleration of Auxilium employee equity awards at closing								$ 37,600		37,600
Asset impairment charges	$ 3,518,100	$ 93,500	$ 40,000	$ 129,600	$ 139,900	$ 923,600	$ 70,200	7,000	3,781,165	1,140,709	22,542
Acquisition-related and integration items	7,400	19,500	48,200	12,600	54,100	(27,700)	44,200	34,600	87,601	105,250	77,384
Loss on extinguishment of debt									0	67,484	31,817
Costs associated with unused financing commitments						64,300	2,300	11,800	0	78,352	0
Other-than-temporary impairment of equity investment							18,900		0	18,869	0
Severance costs	37,100	9,800	22,200	38,500	55,200	22,700	5,800	41,800	57,900	60,200	14,400
Building costs										13,300
Remaining lease obligations net of sublease income										7,900
Transaction costs									63,800	170,900	77,400
Change in fair value of contingent consideration	$ (1,000)	$ 11,600	$ 23,900	$ (10,700)	$ 17,900	$ (80,300)	$ (2,500)	$ (800)	23,823	(65,640)	0
Inventory Write-Offs
Segment Reporting Information [Line Items]
Restructuring expenses									24,500	41,200
Other Restructuring Costs
Segment Reporting Information [Line Items]
Restructuring expenses									25,100
Segment Reconciling Items
Segment Reporting Information [Line Items]
Corporate unallocated costs									189,043	171,242	128,303
Amortization of intangible assets									876,451	561,302	218,712
Inventory step-up and certain manufacturing costs that will be eliminated pursuant to integration plans									125,699	249,464	65,582
Upfront and milestone payments to partners									8,330	16,155	51,774
Separation benefits and other cost reduction initiatives									107,491	125,407	25,760
Impact of Voltaren® Gel generic competition									(7,750)	0	0
Acceleration of Auxilium employee equity awards at closing									0	37,603	0
Certain litigation-related charges, net									23,950	37,082	42,084
Asset impairment charges									3,781,165	1,140,709	22,542
Acquisition-related and integration items									87,601	105,250	77,384
Loss on extinguishment of debt									0	67,484	31,817
Costs associated with unused financing commitments									0	78,352	0
Other-than-temporary impairment of equity investment									0	18,869	0
Foreign currency impact related to the remeasurement of intercompany debt instruments									366	(25,121)	(13,153)
Excise Tax									0	0	54,300
Other, net									(3,547)	(1,152)	42,125
Operating Segments
Segment Reporting Information [Line Items]
Total consolidated loss from continuing operations before income tax									$ 1,717,622	$ 1,517,996	$ 1,074,219